| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.7B | $0.6B | $0.2B | $-0.1B | $0.3B | $0.4B | $0.1B | $0.1B |
| EPS (Basic) | $3.52 | $2.73 | $0.73 | $-0.33 | $1.06 | $1.15 | $0.33 | $0.33 |
| EPS (Diluted) | $3.46 | $2.68 | $0.72 | $-0.33 | $1.04 | $1.13 | $0.32 | $0.33 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $29.7B | $30.1B | $29.2B | $28.8B | $29.2B | $30.8B | $32.7B | $26.6B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $4.2B | $4.7B | $4.1B | $4.6B | $4.3B | $4.5B | $5.6B | $2.6B |
| Total Liabilities | $27.3B | $27.9B | $27.3B | $27.1B | $27.1B | $28.2B | $29.4B | $23.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.5B | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.4B | $-0.3B | $-0.1B | $0.0B | $-0.0B | $-0.2B | $-0.0B | $-0.1B |
| Investing Cash Flow | $1.0B | $0.7B | $-0.0B | $1.1B | $2.6B | $0.9B | $-2.3B | $-3.3B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.1B | $0.2B | $-0.3B | $-0.9B | $-2.6B | $-1.9B | $5.4B | $4.4B |